Smoking in United States of America
In the United States of America, smoking is allowed but tobacco products should follow some regulations. Under these regulations, health warnings on tobacco packaging including cigarettes are mandatory, the minimum legal age for their sales is 21 years, and there are no federal legal restrictions on smoking in public places. While tobacco advertising is regulated, not all forms of their advertising are banned. An excise tax of 32.16% with a total taxation rate of 37.36% is applied on cigarettes. Cigarettes can legally be sold with authorised documents. They may also be purchased through vending machines as well as through online channels. Importing cigarettes for trade is allowed with an appropriate import license. Despite these control measures, prevalence data show that smoking remains an important public health issue in the United States. There were 39.8 million current smokers in the country in 2024. This represents an overall adult smoking prevalence of 14.1%, with higher prevalence among men (17.1%) than among women (11.1%). In comparison, the overall current smoking prevalence was 12.3% in 2022. The adult daily smoking prevalence was recorded to be 10.01% in 2020. Smoking-related mortality also remains significant in the country. In 2021, smoking resulted in 360,370 deaths, including 216,986 male deaths and 143,383 female deaths. This shows that smoking accounted for 10.38% of all deaths in the United States in 2021, with a higher rate among men (11.9%) than among women (8.7%).
Read articles from United States of America
August 12, 2026 by daily-pouch.com
Media Watch: Huffington Post on Nicotine Pouches
Media coverage can shape public understanding before evidence has a chance to. When nicotine pouches are framed mainly through alarm, important distinctions are often lost: they are smoke-free, they do not involve combustion, and they should not be assessed as if they were cigarettes. Scrutiny is necessary, especially around youth access and product standards, but reporting should not turn uncertainty into panic. Public health is better served by context than by headlines that make every nicotine product sound the same.
August 12, 2026 by clearingtheair.eu
US tobacco experts shift stance to back vaping as quit-smoking option
A shift among tobacco experts matters because it changes what smokers hear from the people shaping the debate. Backing vaping as a quit-smoking option does not mean ignoring risk; it means recognising that continued smoking carries far greater harm. For adults who have not stopped through conventional routes, e-cigarettes may offer a practical way out of combustion. Public health advice should reflect that evidence clearly, without stigma making useful options harder to discuss.
August 11, 2026 by planetofthevapes.co.uk
Scientists Stand Corrected
Science should be able to correct itself — that is part of its strength. In nicotine policy, the problem comes when early claims are treated as settled truth long after the evidence has moved on. Corrections matter because public understanding of vaping, risk and smoking is shaped by what researchers, media and regulators choose to repeat. Public health should be willing to update its message when the data no longer supports the alarm.
August 10, 2026 by umaryland.edu
Benefits of Smoking Cessation Far Outweigh Risks of E-Cigarettes
The central comparison is not between vaping and doing nothing. It is between the risks of e-cigarettes and the far greater harms of continued smoking. For adults who smoke, the benefits of stopping combustible tobacco can substantially outweigh the uncertainties associated with switching to lower-risk nicotine products. Public health advice should make that hierarchy clear: quit smoking completely where possible, but do not let fear of imperfect alternatives keep people using cigarettes.
August 10, 2026 by umaryland.edu
Benefits of Smoking Cessation Far Outweigh Risks of E-Cigarettes
The central comparison is not between vaping and doing nothing. It is between the risks of e-cigarettes and the far greater harms of continued smoking. For adults who smoke, the benefits of stopping combustible tobacco can substantially outweigh the uncertainties associated with switching to lower-risk nicotine products. Public health advice should make that hierarchy clear: quit smoking completely where possible, but do not let fear of imperfect alternatives keep people using cigarettes.
August 10, 2026 by regulatorwatch.com
Lumped In | Nicotine-Free Vapes, Guilt by Association? | RegWatch
Nicotine-free vapes show how easily regulation can drift from risk assessment into guilt by association. A product does not become equivalent to smoking simply because it sits near nicotine in the public debate. If rules are based on category suspicion rather than exposure, use and actual harm, they risk confusing consumers and weakening trust in public health. Regulation should be precise enough to distinguish what products contain, how they are used and what risks they genuinely present.
August 10, 2026 by regulatorwatch.com
Lumped In | Nicotine-Free Vapes, Guilt by Association? | RegWatch
Nicotine-free vapes show how easily regulation can drift from risk assessment into guilt by association. A product does not become equivalent to smoking simply because it sits near nicotine in the public debate. If rules are based on category suspicion rather than exposure, use and actual harm, they risk confusing consumers and weakening trust in public health. Regulation should be precise enough to distinguish what products contain, how they are used and what risks they genuinely present.
August 07, 2026 by clearingtheair.eu
Exclusive vaping rises 18.8% a year as US adults move away from smoking, study shows
The movement away from smoking is already happening in the data. A study showing exclusive vaping rising by 18.8% a year among US adults suggests that many people are not simply adding nicotine products, but replacing cigarettes with smoke-free alternatives. That distinction matters: full switching is where harm reduction has the greatest potential. Policy should pay attention to these behavioural shifts instead of treating all nicotine use as a failure.
August 07, 2026 by substack.com
Responses to FDA Tobacco Regulatory Actions
Regulatory meetings should be judged by whether they bring public health closer to real-world solutions. Responses to the FDA’s tobacco regulatory agenda show how wide the gap remains between precaution, evidence and the needs of adults who smoke. If the process treats lower-risk nicotine products mainly as a threat, it risks missing their potential role in reducing exposure to combustible tobacco. Better regulation starts with listening to evidence, consumers and unintended consequences — not only institutional caution.
August 06, 2026 by tobaccoreporter.com
Experts Recommend Physicians Use Vape to Help Smokers Quit
Doctors are often the first trusted voice a smoker hears when trying to quit. If evidence supports vaping as a cessation aid, clinicians should be able to discuss it honestly rather than avoid the subject because of stigma. The goal is not to promote nicotine use, but to help people move away from combustible tobacco when other methods have not worked. Smoking cessation advice should reflect the full range of evidence-based options available to adults.